HIKMA FDA Approval ANDA 206646

ANDA 206646

HIKMA

FDA Drug Application

Application #206646

Application Sponsors

ANDA 206646HIKMA

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORAL10MG0DALFAMPRIDINEDALFAMPRIDINE

FDA Submissions

UNKNOWN; ORIG1AP2018-10-24STANDARD
LABELING; LabelingSUPPL2AP2020-08-13STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null15

TE Codes

001PrescriptionAB

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206646
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"DALFAMPRIDINE","activeIngredients":"DALFAMPRIDINE","strength":"10MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/24\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"08\/13\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-08-13
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.